US$ 22.15
melanotan 2 but (MT-II) | ≥99% Pure Melanotan II (MT-2) Research Peptide
Description
technical replicates representative from 3 independent experiments)

An aggressive and drug-resistant form of breast cancer, known as FOXM1 overexpression, is associated with a dismal prognosis

If pregnant, or breastfeeding, or if you are taking medication, or on medical care, consult your physician prior to use

Don't shake or get aggressive with it

New Zealand Researchers should conduct in-depth studies to fully understand the risks and mechanisms involved

doi: 10.1006/niox.1997.0124
